WO2006005461A3 - Diagnostic et traitement des maladies associees au recepteur 27 couple aux proteines g (rcpg 27) - Google Patents
Diagnostic et traitement des maladies associees au recepteur 27 couple aux proteines g (rcpg 27) Download PDFInfo
- Publication number
- WO2006005461A3 WO2006005461A3 PCT/EP2005/007146 EP2005007146W WO2006005461A3 WO 2006005461 A3 WO2006005461 A3 WO 2006005461A3 EP 2005007146 W EP2005007146 W EP 2005007146W WO 2006005461 A3 WO2006005461 A3 WO 2006005461A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diseases
- gpr27
- therapeutics
- diagnostics
- diseases associated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04016640.7 | 2004-07-15 | ||
EP04016640 | 2004-07-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006005461A2 WO2006005461A2 (fr) | 2006-01-19 |
WO2006005461A3 true WO2006005461A3 (fr) | 2006-05-04 |
Family
ID=35149534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/007146 WO2006005461A2 (fr) | 2004-07-15 | 2005-07-02 | Diagnostic et traitement des maladies associees au recepteur 27 couple aux proteines g (rcpg 27) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006005461A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014129895A1 (fr) * | 2013-02-19 | 2014-08-28 | Stichting Vu-Vumc | Moyen et méthode d'augmentation de la sensibilité de cancers à la radiothérapie |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1067183A1 (fr) * | 1998-03-12 | 2001-01-10 | Yamanouchi Pharmaceutical Co. Ltd. | Nouvelles proteines receptrices couplees aux proteines g |
WO2001007482A1 (fr) * | 1999-07-27 | 2001-02-01 | Smithkline Beecham Corporation | Gpr27, un recepteur couple a la proteine g |
WO2002012344A2 (fr) * | 2000-08-09 | 2002-02-14 | Millennium Pharmaceuticals, Inc. | Methodes d'utilisation d'un recepteur (14266) couple aux proteines g humaines |
WO2005083128A2 (fr) * | 2004-02-25 | 2005-09-09 | University Of South Florida | Methodes de prevision de l'issue d'un cancer et signatures genetiques utilisees dans celles-ci |
-
2005
- 2005-07-02 WO PCT/EP2005/007146 patent/WO2006005461A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1067183A1 (fr) * | 1998-03-12 | 2001-01-10 | Yamanouchi Pharmaceutical Co. Ltd. | Nouvelles proteines receptrices couplees aux proteines g |
US20030077662A1 (en) * | 1998-03-12 | 2003-04-24 | Yamanouchi Pharmaceutical Co., Ltd. | Polynucleotides encoding SREB2 receptor |
WO2001007482A1 (fr) * | 1999-07-27 | 2001-02-01 | Smithkline Beecham Corporation | Gpr27, un recepteur couple a la proteine g |
WO2002012344A2 (fr) * | 2000-08-09 | 2002-02-14 | Millennium Pharmaceuticals, Inc. | Methodes d'utilisation d'un recepteur (14266) couple aux proteines g humaines |
WO2005083128A2 (fr) * | 2004-02-25 | 2005-09-09 | University Of South Florida | Methodes de prevision de l'issue d'un cancer et signatures genetiques utilisees dans celles-ci |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL [online] 16 December 2004 (2004-12-16), "Sequence 1 from patent US 6808899.", XP002352460, retrieved from EBI accession no. EM_PRO:AR592971 Database accession no. AR592971 * |
DATABASE Geneseq [online] 15 November 1999 (1999-11-15), "A G protein-coupled receptor protein designated SREB1.", XP002352462, retrieved from EBI accession no. GSN:AAY30532 Database accession no. AAY30532 * |
DATABASE Geneseq [online] 31 May 2002 (2002-05-31), "Human G-protein coupled receptor 14266.", XP002352461, retrieved from EBI accession no. GSN:AAE14597 Database accession no. AAE14597 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006005461A2 (fr) | 2006-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006027147A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur d'adrenomedulline (amdr) | |
WO2005093092A3 (fr) | Diagnostic et traitement de maladies associees au recepteur 44 couple aux proteines g (gpr44) | |
WO2005106012A3 (fr) | Diagnostics et therapeutiques de maladies associees a la dipeptidyl-peptidase 1 (dpp1) | |
WO2006010517A3 (fr) | Diagnostic et traitement therapeutique des maladies associees a la proteine d'activation des fibroblastes (fap) | |
WO2006005469A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre les maladies associees au recepteur de glucagon (gcgr) | |
WO2005100990A3 (fr) | Methodes diagnostiques et therapeutiques pour des maladies associees au purinocepteur 2 de type y (p2y2) | |
WO2005103684A3 (fr) | Diagnostics et methodes therapeutiqeus pour des maladies associees au recepteur 1 de la chimiokine cx3c | |
WO2006021343A3 (fr) | Diagnostic et therapie de maladies associees au recepteur 3a de la 5-hydroxytryptamine (5-ht3a) | |
WO2005076007A3 (fr) | Diagnostics et traitements de maladies associees au recepteur p2y12 couple a la proteine g (p2y12) | |
WO2005101001A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre des maladies associees au recepteur couple a la proteine g, element c, groupe 5, famille c (gprc5c) | |
WO2005093091A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees au recepteur 26 couple a la proteine g (gpr26) | |
WO2005031345A3 (fr) | Diagnostic et therapeutique de maladies associees au recepteur couple a la proteine g adipor2 (adipor2) | |
WO2006005461A3 (fr) | Diagnostic et traitement des maladies associees au recepteur 27 couple aux proteines g (rcpg 27) | |
WO2005073729A3 (fr) | Diagnostic et traitement de maladies associees au recepteur p2y11 couple a une proteine g (p2y11) | |
WO2005075983A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a un recepteur nucleaire humain nr4a3 (nr4a3) | |
WO2005113788A3 (fr) | Diagnostics et therapeutiques pour des maladies associees a la kinase 6 associee au recepteur couple a une proteine g (grk6) | |
WO2005106486A3 (fr) | Diagnostics et therapeutiques de maladies associees a la dipeptidyl-peptidase 3 (dpp3) | |
WO2006005470A3 (fr) | Agents diagnostiques et therapeutiques pour des maladies associees au recepteur couple a la proteine g lie au mas (mrge) | |
WO2006008003A3 (fr) | Agents diagnostiques et therapeutiques pour pathologies associees au recepteur 1 de peptide intestinal vasoactif (vpac1) | |
WO2005119263A3 (fr) | Diagnostic et traitement des maladies associees au recepteur couple aux proteines g 92 (gpr92) | |
WO2005101011A3 (fr) | Agents diagnostiques therapeutiques pour des maladies associees a lxr-alpha (lxra) | |
WO2006040047A3 (fr) | Diagnostics et therapeutiques pour des maladies associees a la kinase citron agissant sur rho/rac | |
WO2006005460A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a la sous-famille 2 des recepteurs nucleaires, groupe e, membre 1 (nr2e1) | |
WO2005101009A3 (fr) | Outils diagnostiques et therapeutiques pour maladies associees au recepteur 2 de tachykinine (tacr2) | |
WO2005075990A3 (fr) | Diagnostics et therapeutiques pour maladies associees au recepteur nucleaire humain nr4a2 (nr4a2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |